|
Variables reported to the RARC | Variables reported to the RAC |
|
(i) Patients’ personal data | (i) Patients’ sociodemographic profile |
(ii) Patients’ sociodemographic profile | (ii) Patients’ biopsychosocial status |
(iii) Patients’ biopsychosocial status | (iii) Average daily dose of methadone per patient |
(iv) Years of drug use | (iv) Remaining amount of methadone |
(v) Information about types of treatment currently and previously received | (v) Number of new patients |
(vi) Date of initiation of MAT | (vi) Number of dropouts and reasons for dropout |
(vii) Clinical diagnosis based on ICD-10 | (vii) Criminal charges |
(viii) Daily dose of methadone prescribed | (viii) Concurrent illnesses including HIV, hepatitis B (HBV), hepatitis C (HCV), and tuberculosis |
(ix) Changes in prescribed dose of methadone and reason for the changes | |
(x) Number of new patients | |
(xi) Number of dropouts and reasons for dropout | |
(xii) Criminal charges | |
(xiii) Concurrent illnesses including HIV, hepatitis B, hepatitis C, and tuberculosis | |
(xiv) Laboratory test results | |
(xv) Results of psychological assessment with dates | |
(a) Short form of Minnesota Multiphasic Personality Inventory (MMPI-Short) | |
(b) Addiction Severity Index | |
(c) Zung Self-Rating Depression Scale | |
(d) WHO QOL-100 (Quality of Life) | |
(xvi) Description of side effects related to MAT with observation dates | |
(xvii) Description of changes in patients’ social well-being | |
(xvii) Outcomes of therapy | |
(xix) Reasons for exclusion from MAT (if applicable) | |
|